PubRank

Abatacept in Juvenile Dermatomyositis (AID)

Clinical Trial ID NCT02594735

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02594735

Top papers

Rank Title Journal Year PubWeight™‹?›
1 B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993 3.57
2 Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial. Arthritis Rheum 2013 3.55
3 Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 2008 2.16
4 International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum 2004 1.66
5 Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment. Best Pract Res Clin Rheumatol 2009 1.27
6 The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Ann Rheum Dis 2012 1.15
7 Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 2010 1.12
8 Costimulatory markers in muscle of patients with idiopathic inflammatory myopathies and in cultured muscle cells. Clin Immunol 1999 1.05
9 The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis. Arthritis Care Res (Hoboken) 2010 1.05
10 Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies. Am J Pathol 1999 0.88
11 Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions. J Immunol 1998 0.86
12 Subcutaneous abatacept for the treatment of rheumatoid arthritis. Rheumatology (Oxford) 2013 0.84
13 Abatacept for treatment of refractory polymyositis. Joint Bone Spine 2011 0.83
14 Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis. J Pediatr 2012 0.81
15 Successful treatment of refractory anti-signal recognition particle myopathy using abatacept. Rheumatology (Oxford) 2013 0.77
Next 100